Teladoc Health Stock Forecast

Stock Price Forecast

The 17 analysts that cover Teladoc Health stock have a consensus rating of "Buy" and an average price target of $7.59, which forecasts a 40.04% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $11.

Price Target: $7.59 (+40.04%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.00	$7.59	$7.00	$11
Change	-7.75%	+40.04%	+29.15%	+102.95%

Analyst Ratings

The average analyst rating for Teladoc Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2	2	2	3
Buy	4	2	2	2	1	2
Hold	11	10	10	10	12	13
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	14	14	14	15	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lisa Gill JP Morgan	JP Morgan	Hold Maintains $9 → $7	Hold	Maintains	$9 → $7	+29.15%	Mar 13, 2026
George Hill Deutsche Bank	Deutsche Bank	Hold → Strong Buy Upgrades $11	Hold → Strong Buy	Upgrades	$11	+102.95%	Mar 10, 2026
Daniel Grosslight Citigroup	Citigroup	Hold Maintains $9 → $6	Hold	Maintains	$9 → $6	+10.70%	Mar 3, 2026
Michael Wiederhorn Oppenheimer	Oppenheimer	Buy Maintains $12 → $7	Buy	Maintains	$12 → $7	+29.15%	Mar 3, 2026
Richard Close Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $12 → $10	Strong Buy	Maintains	$12 → $10	+84.50%	Feb 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

2.57B

from 2.53B

1.74%

from 2.53B

Revenue Next Year

2.61B

from 2.57B

1.24%

from 2.57B

EPS This Year

-0.88

from -1.14

EPS Next Year

-0.76

from -0.88

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	2.03B	2.41B	2.60B	2.57B	2.53B	2.57B	2.61B
Revenue Growth	85.81%	18.41%	8.13%	-1.26%	-1.54%	1.74%	1.24%
EPS	-2.73	-84.60	-1.34	-5.87	-1.14	-0.88	-0.76
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	28	24

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	2.7B	2.8B
Avg	2.6B	2.6B
Low	2.4B	2.4B

Revenue Growth

Revenue Growth	2026	2027
High	7.9%	8.5%
Avg	1.7%	1.2%
Low	-4.1%	-5.7%

EPS Forecast

EPS	2026	2027
High	-0.45	-0.43
Avg	-0.88	-0.76
Low	-1.25	-1.19

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.